Nathan D. Jorgensen, CFO of Voyager Therapeutics ($VYGR), made two open market sales of company shares over the past year, totaling $54,242. His latest sale occurred on February 24, 2026. These transactions rank 10,306th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. He reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | S | Common Stock | 4668 | $3.77 | 151,416.0000 | 58,803,015 | 2.99% | 0.01% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | A | Common Stock | 32250 | $0.00 | 156,084.0000 | 58,803,015 | 26.04% | 0.05% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 150500 | $0.00 | 150,500.0000 | 58,803,015 | 9999.99% | 0.26% |
| Oct. 3, 2025 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | S | Common Stock | 7666 | $4.78 | 123,834.0000 | 58,803,015 | 5.83% | 0.01% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | A | Common Stock | 51500 | $0.00 | 131,500.0000 | 57,667,543 | 64.38% | 0.09% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 103000 | $0.00 | 103,000.0000 | 57,667,543 | 9999.99% | 0.18% |
| Oct. 1, 2024 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | A | Common Stock | 80000 | $0.00 | 80,000.0000 | 57,851,110 | 9999.99% | 0.14% |
| July 8, 2024 | Voyager Therapeutics, Inc. | $VYGR | Jorgensen Nathan D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 57,721,934 | 9999.99% | 0.35% |
| May 6, 2024 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F | Common Stock | 834 | $1.75 | 189,403.0000 | 0 | 0.44% | 0.00% |
| May 1, 2024 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F | Common Stock | 917 | $1.77 | 190,237.0000 | 0 | 0.48% | 0.00% |
| March 1, 2024 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F | Common Stock | 6310 | $2.27 | 191,154.0000 | 0 | 3.20% | 0.00% |
| Feb. 6, 2024 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F | Common Stock | 985 | $2.32 | 197,464.0000 | 0 | 0.50% | 0.00% |
| Jan. 29, 2024 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2024 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | A | Common Stock | 50000 | $0.00 | 198,449.0000 | 0 | 33.68% | 0.00% |
| Nov. 6, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | F | Common Stock | 834 | $1.82 | 145,647.0000 | 0 | 0.57% | 0.00% |
| Sept. 1, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | F | Common Stock | 6310 | $2.67 | 146,481.0000 | 0 | 4.13% | 0.00% |
| Aug. 7, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | F | Common Stock | 834 | $2.67 | 152,791.0000 | 0 | 0.54% | 0.00% |
| May 8, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | F | Common Stock | 834 | $4.14 | 153,625.0000 | 0 | 0.54% | 0.00% |
| March 1, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | F | Common Stock | 6310 | $5.51 | 154,459.0000 | 0 | 3.92% | 0.00% |
| Feb. 6, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Vor Biopharma Inc. | $VOR | Jorgensen Nathan D. | Chief Financial Officer | A | Common Stock | 45500 | $0.00 | 160,769.0000 | 0 | 39.47% | 0.00% |